Peter T. Scardino

81.3k total citations · 16 hit papers
738 papers, 52.0k citations indexed

About

Peter T. Scardino is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Peter T. Scardino has authored 738 papers receiving a total of 52.0k indexed citations (citations by other indexed papers that have themselves been cited), including 620 papers in Pulmonary and Respiratory Medicine, 154 papers in Rheumatology and 149 papers in Surgery. Recurrent topics in Peter T. Scardino's work include Prostate Cancer Diagnosis and Treatment (538 papers), Prostate Cancer Treatment and Research (488 papers) and Urologic and reproductive health conditions (143 papers). Peter T. Scardino is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (538 papers), Prostate Cancer Treatment and Research (488 papers) and Urologic and reproductive health conditions (143 papers). Peter T. Scardino collaborates with scholars based in United States, United Kingdom and Sweden. Peter T. Scardino's co-authors include Michael W. Kattan, James A. Eastham, Thomas M. Wheeler, Makoto Ohori, Andrew J. Vickers, Fernando J. Bianco, Hedvig Hricak, Victor E. Reuter, Andrew J. Stephenson and Kevin M. Slawin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Peter T. Scardino

720 papers receiving 50.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

2006 1.2k citations William C. Huang, Andrew S. Levey et al. profile →
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

1994 1.1k citations Peter T. Scardino et al. profile →
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

2011 890 citations Brett S. Carver, John Wongvipat et al. Cancer Cell profile →
Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

1998 860 citations Kevin M. Slawin, Peter T. Scardino et al. profile →
CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTS

2002 733 citations Farhang Rabbani, Thomas M. Wheeler et al. profile →
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

2007 633 citations Peter T. Scardino, Michael W. Kattan et al. Journal of Clinical Oncology profile →
Variations in Morbidity after Radical Prostatectomy

2002 617 citations Michael W. Kattan, Peter T. Scardino et al. profile →
Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer

1999 582 citations Michael W. Kattan, Thomas M. Wheeler et al. Journal of Clinical Oncology profile →
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

2011 548 citations Jack Cuzick, Gabrielle Fisher et al. profile →
Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy

2005 522 citations Peter T. Scardino, James A. Eastham et al. Journal of Clinical Oncology profile →
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

2009 490 citations Brett S. Carver, Anuradha Gopalan et al. profile →
A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

1991 469 citations Peter T. Scardino et al. profile →
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

2011 468 citations Peter T. Scardino, James A. Eastham et al. profile →
Imaging Prostate Cancer: A Multidisciplinary Perspective

2007 436 citations Hedvig Hricak, Peter T. Scardino et al. Radiology profile →
Risk Factors for Urinary Incontinence after Radical Prostatectomy

1996 413 citations James A. Eastham, Michael W. Kattan et al. profile →
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

2007 324 citations Hikmat Al‐Ahmadie, Angel M. Serio et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter T. Scardino United States	124	40.7k	10.6k	10.1k	8.2k	7.1k	738	52.0k
Peter R. Carroll United States	110	30.7k 0.8×	6.2k 0.6×	10.2k 1.0×	7.8k 1.0×	7.5k 1.1×	880	46.0k
Jonathan I. Epstein United States	121	46.9k 1.2×	16.6k 1.6×	15.9k 1.6×	12.3k 1.5×	8.6k 1.2×	991	63.6k
Alan W. Partin United States	94	31.0k 0.8×	7.9k 0.7×	6.5k 0.6×	7.6k 0.9×	4.9k 0.7×	657	40.3k
Patrick C. Walsh United States	104	29.5k 0.7×	9.4k 0.9×	8.0k 0.8×	5.8k 0.7×	3.9k 0.6×	577	40.5k
Francesco Montorsi Italy	113	32.9k 0.8×	11.3k 1.1×	18.0k 1.8×	7.6k 0.9×	5.9k 0.8×	1.7k	59.5k
Theodorus van der Kwast Netherlands	86	20.0k 0.5×	4.4k 0.4×	7.9k 0.8×	8.2k 1.0×	5.1k 0.7×	651	32.9k
Michael L. Blute United States	100	28.4k 0.7×	3.8k 0.4×	9.7k 1.0×	13.0k 1.6×	6.6k 0.9×	507	36.2k
Thomas M. Wheeler United States	95	17.2k 0.4×	6.6k 0.6×	6.0k 0.6×	5.7k 0.7×	4.6k 0.6×	403	29.8k
Eric A. Klein United States	88	19.7k 0.5×	3.5k 0.3×	6.0k 0.6×	5.0k 0.6×	4.8k 0.7×	733	29.8k
James A. Eastham United States	87	21.8k 0.5×	6.6k 0.6×	6.0k 0.6×	2.3k 0.3×	4.3k 0.6×	538	27.3k

Countries citing papers authored by Peter T. Scardino

Since Specialization

Citations

This map shows the geographic impact of Peter T. Scardino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Scardino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Scardino more than expected).

Fields of papers citing papers by Peter T. Scardino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter T. Scardino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Scardino. The network helps show where Peter T. Scardino may publish in the future.

Co-authorship network of co-authors of Peter T. Scardino

This figure shows the co-authorship network connecting the top 25 collaborators of Peter T. Scardino. A scholar is included among the top collaborators of Peter T. Scardino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter T. Scardino. Peter T. Scardino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Touijer, Karim, Emily Vertosick, Daniel D. Sjoberg, et al.. (2024). Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection. European Urology. 87(2). 253–260. 8 indexed citations

Vertosick, Emily, Spyridon P. Basourakos, James A. Eastham, et al.. (2021). Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms. European Urology Open Science. 30. 13–15. 6 indexed citations

Cuzick, Jack, Steven Stone, Gabrielle Fisher, et al.. (2015). Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort. British Journal of Cancer. 113(3). 382–389. 109 indexed citations

Coleman, Jonathan & Peter T. Scardino. (2013). Targeted prostate cancer ablation. Current Opinion in Urology. 23(2). 123–128. 17 indexed citations

Fisher, Gabrielle, Zi Yang, Sakunthala C. Kudahetti, et al.. (2013). Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort. British Journal of Cancer. 108(2). 271–277. 88 indexed citations

Ulmert, David, Michael J. Evans, Jason P. Holland, et al.. (2012). Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen. Cancer Discovery. 2(4). 320–327. 58 indexed citations

Carver, Brett S., John Wongvipat, Haley Hieronymus, et al.. (2011). Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer. Cancer Cell. 19(5). 575–586. 890 indexed citations breakdown →

Shukla‐Dave, Amita, Hedvig Hricak, Oğuz Akın, et al.. (2011). Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. British Journal of Urology. 109(9). 1315–1322. 85 indexed citations

Vickers, Andrew J., Angel M. Cronin, Monique J. Roobol, et al.. (2010). A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam. Clinical Cancer Research. 16(12). 3232–3239. 95 indexed citations

10.

Vickers, Andrew J., Angel M. Cronin, Monique J. Roobol, et al.. (2010). Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication. Journal of Clinical Oncology. 28(15). 2493–2498. 167 indexed citations

11.

Thomsen, Martin K., Laurence Ambroisine, Sarah Wynn, et al.. (2010). SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation. Cancer Research. 70(3). 979–987. 114 indexed citations

12.

Klein, Robert J., Christer Halldén, Angel M. Cronin, et al.. (2010). Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer. Cancer Prevention Research. 3(5). 611–619. 45 indexed citations

13.

Gopalan, Anuradha, Margaret Leversha, Jaya M. Satagopan, et al.. (2009). TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy. Cancer Research. 69(4). 1400–1406. 189 indexed citations

14.

Ouyang, Xuesong, Walter J. Jessen, Hikmat Al‐Ahmadie, et al.. (2008). Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. Cancer Research. 68(7). 2132–2144. 108 indexed citations

15.

Huang, William C., Andrew S. Levey, Angel M. Serio, et al.. (2007). Laparoscopy: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study - Commentary. Iris Unimore (University of Modena and Reggio Emilia). 21(2). 126–127. 1 indexed citations

16.

Howard, Michael A., et al.. (2005). Evaluation of Genitofemoral Nerve Donor Site Morbidity After Radical Prostatectomy. Annals of Plastic Surgery. 55(1). 57–62. 9 indexed citations

17.

Pucar, Darko, Amita Shukla‐Dave, Hedvig Hricak, et al.. (2005). Prostate Cancer: Correlation of MR Imaging and MR Spectroscopy with Pathologic Findings after Radiation Therapy–Initial Experience. Radiology. 236(2). 545–553. 146 indexed citations

18.

Graefen, Markus, Pierre I. Karakiewicz, Ilias Cagiannos, et al.. (2002). A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urologic Oncology Seminars and Original Investigations. 7(4). 141–146. 59 indexed citations

19.

Vicini, Frank A., Alvaro A. Martinez, Gerald E. Hanks, et al.. (2002). An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up. Cancer. 95(10). 2126–2135. 42 indexed citations

20.

Chang, Shine, Stephen D. Hursting, John H. Contois, et al.. (2001). Leptin and prostate cancer. The Prostate. 46(1). 62–67. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact